Published online December 1, 2005
PEDIATRICS Vol. 117 No. 1 January 2006, pp. e76-e83 (doi:10.1542/peds.2005-0629)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lanari, M.
Right arrow Articles by Faldella, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lanari, M.
Right arrow Articles by Faldella, G.
Related Collections
Right arrow Infectious Disease & Immunity

Neonatal Cytomegalovirus Blood Load and Risk of Sequelae in Symptomatic and Asymptomatic Congenitally Infected Newborns

Marcello Lanari, MD, PhDa, Tiziana Lazzarotto, DScb, Valentina Venturi, MDa, Irene Papa, MDa, Liliana Gabrielli, MDb, Brunella Guerra, MDc, Maria Paola Landini, MDb and Giacomo Faldella, MDa

a Departments of Preventive Pediatrics and Neonatology
b Clinical and Experimental Medicine (Clinical Unit of Microbiology)
c Obstetrics and Gynecology, St Orsola Malpighi General Hospital, University of Bologna, Bologna, Italy

OBJECTIVE. Human cytomegalovirus (CMV) is a ubiquitous human-specific DNA virus and is the main cause of congenital virus infection in developed countries leading to psychomotor impairment and deafness. Diagnostic techniques for CMV detection have greatly improved during recent years with the advent of sophisticated serological and virological methods. The aim of the present study was to assess the diagnostic and prognostic value of detection and quantification of virus in neonatal blood samples of symptomatic and asymptomatic newborns with CMV congenital infection.

METHODS. Between January 1997 and December 2003, we studied 99 newborns who were born to women with primary, recurrent, and undefined CMV infection during pregnancy. CMV congenital infection was identified by isolation of the virus in urine within the second week of life. Fifty-eight of 99 infants were infected and were assessed clinically for disease in the newborn period and classified as having symptomatic or asymptomatic infection on the basis of physical, instrumental, and laboratory findings. The infants were followed up from birth according to a protocol of the tertiary NICU at the University of Bologna in a prospective study of long-term sequelae of congenital infection. Forty-seven blood samples were obtained from 47 infants in the neonatal period: 34 were examined for pp65 antigenemia test and 44 for qualitative and quantitative polymerase chain reaction (PCR and qPCR). Sequelae at 12 months were evaluated in a group of 50 infants.

RESULTS. Antigenemia was positive in only 10 of 34 samples of infected newborns (29.4% sensitivity). PCR was performed in 44 samples of infected newborns and was positive in all (100% sensitivity). qPCR showed a finding of ≥100 copies per 105 of polymorphonuclear leukocytes (PMNLs) in 39 of 44 samples; in the other 5 cases, the number of copies per 105 PMNLs was <100. Between symptomatic and asymptomatic newborns, the mean values of viral blood load determined by qPCR turned out to be significantly higher in symptomatic newborns. Mean values of neonatal blood viral load were statistically higher in newborns who developed sequelae than in those who did not. Of 20 children with a neonatal viral blood load of <1000 copies per 105 PMNLs, 19 did not develop sequelae (negative predictive value: 95%), whereas 2 of 3 with a viral blood load of >10000 copies did develop sequelae.

CONCLUSIONS. Different viremia value ranges are correlated to a different risk of sequelae: ~70% sequelae were found in newborns with a qPCR higher than 10000 copies per 105 PMNLs. Low neonatal viral blood load detected by pp65 antigenemia test and qPCR was highly predictive of absence of sequelae: DNAemia <1000 copies per 105 PMNLs has a negative predictive value of 95%. As an independent predictive factor of outcome, neonatal viremia is another useful element for neonatal counseling and therapeutic choices in symptomatic and asymptomatic newborns.

Key Words: cytomegalovirus • DNAemia • pp65 antigenemia • sequelae • sensorineural hearing loss • neurodevelopmental defects • prognostic value

Abbreviations: CMV—cytomegalovirus • PCR—polymerase chain reaction • Ig—immunoglobulin • ALT—alanine aminotransferase • PMNLs—polymorphonuclear leucocytes • qPCR—quantitative PCR • BSER—brainstem evoked response • PPV—positive predictive value • NPV—negative predictive value

Accepted Jul 1, 2005.




This article has been cited by other articles:


Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
S Walter, C Atkinson, M Sharland, P Rice, E Raglan, V C Emery, and P D Griffiths
Congenital cytomegalovirus: association between dried blood spot viral load and hearing loss
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2008; 93(4): F280 - F285.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
O. Soetens, C. Vauloup-Fellous, I. Foulon, P. Dubreuil, B. De Saeger, L. Grangeot-Keros, and A. Naessens
Evaluation of Different Cytomegalovirus (CMV) DNA PCR Protocols for Analysis of Dried Blood Spots from Consecutive Cases of Neonates with Congenital CMV Infections
J. Clin. Microbiol., March 1, 2008; 46(3): 943 - 946.
[Abstract] [Full Text] [PDF]